Resources Contact Us Home
Farnesoid activated receptor polypeptides, and nucleic acid encoding the same

Image Number 4 for United States Patent #6005086.

Farnesyl pyrophosphate, the metabolically active form of farnesol, is a key precursor in the synthesis of cholesterol, carotenoids, steroid hormones, bile acids and other molecules involved in cellular growth and metabolism. A nuclear receptor has been identified that is transcriptionally activated by farnesol and related molecules. This novel signaling pathway can be modulated by the use of key metabolic intermediates (or analogs and/or derivatives thereof) as transcriptional regulatory signals.

  Recently Added Patents
Apparatus and methods for temperature-based control of communication device operations
Glyoxalation of vinylamide polymer
Lane departure control system
Method for improving the textural attributes of baked snack foods
Captive latch for fluorescent light fixture
Methods and systems for presenting an inhalation experience
Evaluation device and method for providing a transceiver system with performance information thereof
  Randomly Featured Patents
Method for preparing C.sub.3 -C.sub.4 olefins and vinylaromatic compounds
Fluid cracking catalyst based on silica sol matrix
System for monitoring a characteristic of a product
Memory burst operations in which address count bits are used as column address bits for one, but not both, of the odd and even columns selected in parallel.
Liquid propellant gun
Multi-layer dressings, systems, and methods for applying reduced pressure at a tissue site
Single panel color image projection system
Phosphorus-containing compounds and lubricants containing same
Semi-rigid penial prosthesis for the treatment of impotence in the erection
Arrangement of interactive processors for control of ports